[60]Fullerene for Medicinal Purposes, A Purity Criterion towards Regulatory Considerations.

ABSTRACT: Since the early nineties countless publications have reported promising medicinal applications for [60]fullerene (C₆₀) related to its unparalleled affinity towards free radicals. Yet, until now no officially approved C₆₀-based drug has reached the market, notably because of the alleged dangers of C₆₀. Nevertheless, since the publication of the effects of C₆₀ on the lifespan of rodents, a myriad of companies started selling C₆₀ worldwide for human consumption without any approved clinical trial. Nowadays, several independent teams have confirmed the safety of pure C₆₀ while demonstrating that previously observed toxicity was due to impurities present in the used samples. However, a purity criterion for C₆₀ samples

SUBMITTER: Keykhosravi S 

PROVIDER: S-EPMC6719231 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature